Cargando…
Aspirin and Statin Use and the Risk of Gallbladder Cancer
SIMPLE SUMMARY: The effects of aspirin on various gastrointestinal cancers have been extensively studied, but the potential protective effect of aspirin and statins on the prevention of gallbladder cancer (GBC) has not been adequately evaluated. The anticancer effect of aspirin has been attributed t...
Autores principales: | Prasai, Kritika, Tella, Sri Harsha, Yadav, Siddhartha, Kommalapati, Anuhya, Mara, Kristin, Mady, Mohamed, Hassan, Mohamed A., Wongjarupong, Nicha, Rodriguez-Payan, Natalia, Borad, Mitesh, Patel, Tushar, Roberts, Lewis R., Mahipal, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967123/ https://www.ncbi.nlm.nih.gov/pubmed/33803387 http://dx.doi.org/10.3390/cancers13051186 |
Ejemplares similares
-
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice
por: Kommalapati, Anuhya, et al.
Publicado: (2021) -
Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date
por: Tella, Sri Harsha, et al.
Publicado: (2019) -
First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination
por: Tella, Sri Harsha, et al.
Publicado: (2022) -
Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
por: Mahipal, Amit, et al.
Publicado: (2019) -
Thyrotoxic Periodic Paralysis: An Underdiagnosed and Under-recognized Condition
por: Tella, Sri Harsha, et al.
Publicado: (2015)